Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel.
Ocul Surf. 2020 Jan;18(1):64-73. doi: 10.1016/j.jtos.2019.09.009. Epub 2019 Sep 28.
To investigate the effect of repetitive magnetic stimulation (RMS) on corneal epithelial permeability in a rabbit model of exposure keratopathy.
61 female New Zealand White (NZW) rabbits were treated on one eye with repetitive magnetic stimulation (RMS) at a frequency of 20 Hz for 15 min. The other eye was untreated. Rabbit eyes were kept open for 2 h to induce acute corneal desiccation. The extent of fluorescein corneal staining was evaluated using EpiView software and the concentration of fluorescein in the anterior chamber was determined by a fluorometer. Safety was evaluated by electroretinogram, spectral domain optical coherence tomography (SD-OCT) and histopathology. Expression pattern of corneal cell markers was determined by immunofluorescence.
A significant decrease in fluorescein concentration in the anterior chamber (54 ± 8.4 ng/ml vs. 146.5 ± 18.6 ng/ml, p = 0.000001) and in corneal surface fluorescein staining score (1.7 ± 0.2 vs. 4.6 ± 0.6, p = 0.00001) was obtained in RMS-treated eyes compared with control eyes, respectively. RMS treatment reduced by nearly 4 fold the percentage of corneal area with epithelial erosions by anterior segment SD-OCT. The therapeutic effect was maintained for at least 3 months. Increased expression of epithelial tight junction protein Zo-1 was observed in treated eyes. SD-OCT and histopathology analysis revealed no pathological changes in the treated or non-treated eyes.
RMS treatment decreases epithelial corneal erosions in a rabbit model of exposure keratopathy, with no indication of pathological changes. RMS may present a novel treatment for protection of corneal epithelium from desiccation.
研究重复磁刺激(RMS)对暴露性角膜炎兔模型角膜上皮通透性的影响。
61 只雌性新西兰白兔(NZW)的一只眼接受 20Hz 频率的重复磁刺激(RMS)治疗 15 分钟。另一只眼未接受治疗。将兔眼保持开放 2 小时以诱导急性角膜干燥。使用 EpiView 软件评估荧光素角膜染色的程度,并通过荧光计测定前房内荧光素的浓度。通过视网膜电图、谱域光相干断层扫描(SD-OCT)和组织病理学评估安全性。通过免疫荧光测定角膜细胞标志物的表达模式。
与对照组相比,RMS 治疗组前房内荧光素浓度(54±8.4ng/ml vs. 146.5±18.6ng/ml,p=0.000001)和角膜表面荧光素染色评分(1.7±0.2 vs. 4.6±0.6,p=0.00001)均显著降低。RMS 治疗组通过眼前节 SD-OCT 检测到的角膜上皮糜烂面积减少近 4 倍。治疗效果至少持续 3 个月。治疗组观察到上皮紧密连接蛋白 Zo-1 的表达增加。SD-OCT 和组织病理学分析显示治疗眼和未治疗眼均无病理变化。
RMS 治疗可减少暴露性角膜炎兔模型的角膜上皮糜烂,无病理变化迹象。RMS 可能为保护角膜上皮免受干燥提供一种新的治疗方法。